AUDITED AS AT 31 December 2023 RM'000 RM'000 Non-current assets Property, plant and equipment 9,962 6,382 Deferred tax assets 1,397 1,397 11,359 7,779 Current assets Inventories 9,886 7,096 Trade receivables 17,349 29,719 Other receivables 4,400 2,086 Contract assets 18,890 14,000其他投资8,953 5,597现金和短期存款38,266 45,406 97,744 97,744 103,904总资产总资产109,103 111,683股票股票 /投资股票54,944 54,944 54,944 54,944合并(赤字) /储备(14,150)(14,150)(14,150)(14,150)(14,150) 78,603 71,012 Non-controlling interests 2 2 Total equity 78,605 71,014 Non-current liabilities Lease liability 164 - Current liabilities Lease liability 234 85 Current tax liabilities 1,283 2,396 Trade payables 13,101 14,882 Other payables 3,503 4,086 Dividend payable - 5,316 Contract liabilities 12,213 13,904 30,334 40,669总负债30,498 40,669总权益和负债109,103 111,683每股净资产
Cash and cash equivalents ($3,564 and $3,522 as of March 31, 2024 and December 31, 2023, respectively, for joint venture) 192,321 $ 142,524 $ Marketable securities 817,314 928,284 Prepaid expenses and other current assets 35,400 12,709 Total current assets 1,045,035 1,083,517 Property and equipment, net 315,644 313,164 Right-of-use assets - finance lease 24,422 25,140 Right-of-use assets - operating lease 54,596 55,863 Other assets 24,281 24,294 Total assets 1,463,978 $ 1,501,978 $ Liabilities, redeemable non-controlling interest and stockholders' equity Current liabilities Accounts payable 11,508 $ 12,959 $ Accrued liabilities 72,331 10,180 Accrued compensation and benefits 8,738 26,043 Operating lease liability, short-term 5,110 5,006 Finance lease liability, short-term 2,986 2,907 Total current liabilities 100,673 57,095 Operating lease liability,长期56,256 57,622财务租赁责任,长期34,314 35,098其他负债13,073 11,986总负债204,316 161,801可兑换的不可兑现的非控制权不可控制的利息1,790 1,770 1,770股东
OCT - MAR'21 Outstanding 1 Accounts Payable Holding Company 9,471.50 Kingfa Science & Technology Co. Ltd China 9,471.50 Subsidiaries of Holding Company 3,141.96 Shanghai Kingfa Science and Tech Co Ltd 79.37 Jaingsu Kingfa Science & Tech Advance Material Co Ltd 1,777.71 Hong Kong Kingfa Development Co Ltd 1.05 Zhuhai Wantong Special Engineering Plastics Co.,Ltd。5.05广东Kingfa Sci。&Tech。(欧洲)57.31总计12,613.46 12,613.46 2应收账款控股公司239.61 Kingfa Science&Technology Co. Ltd中国239.61控股公司294.71上海Kingfa Kingfa Kingfa Technology Development Co.,Ltd. 17.00 Jiangsu Kingfa Kingfa Kingfa King. King.02 King.02.022.02 2. 0. 0. 022. 0. 02. 0. Ltd. 0. 0. 02. 0. Ltd。 Sci。&Tech(Thailand).co。,Ltd 114.87 Kingfa科学技术,(美国)159.82总计534.32 534.32
APC payable (discounted) Behavior Therapy 0005-7894 Hybrid Y Behaviour Research and Therapy 0005-7967 Hybrid Y Behavioural Brain Research 0166-4328 Hybrid Y Behavioural Processes 0376-6357 Hybrid Y Best Practice & Research Clinical Anaesthesiology 1521-6896 Hybrid Y Best Practice & Research Clinical Endocrinology & Metabolism 1521-690X Hybrid Y Best Practice & Research Clinical Gastroenterology 1521-6918 Hybrid Y Best Practice & Research Clinical Haematology 1521-6926 Hybrid Y Best Practice & Research Clinical Obstetrics & Gynaecology 1521-6934 Hybrid Y Best Practice & Research Clinical Rheumatology 1521-6942 Hybrid Y Big Data Research 2214-5796 Hybrid Y Bioactive Carbohydrates and Dietary Fibre 2212-6198 Hybrid Y Biocatalysis and Agricultural Biotechnology 1878-8181 Hybrid Y Biochemical and Biophysical Research Communications 0006-291X Hybrid Y Biochemical Engineering Journal 1369-703X Hybrid Y Biochemical Pharmacology 0006-2952混合Y生化系统学和生态学0305-1978混合Y
如果您在获得 10 年的每月福利金之前死亡,您可以更改受益人,一次性领取剩余的福利金。选中此页背面的相应方框并指定您的受益人。如果您是符合条件的幸存配偶:一次性死亡福利金:您有权指定或更改受益人,在您死亡后领取一次性福利金。选中此页背面的“死亡福利金”方框并指定您的受益人。如果您是符合条件的幸存受抚养子女:一次性死亡福利金:如果会员的配偶依然健在,该人将自动成为您的受益人。如果没有幸存的配偶,您有权指定或更改受益人,在您死亡后领取一次性福利金。勾选此页背面的“死亡抚恤金”框并指定您的受益人。
每年的药物,生物学产品(包括生物仿制药)和放射性药物的支付,CMS根据当前的定价方法来评估药物和生物学的付款,其中包括基于分配的AMB付款分类或传票状态的药物和生物学付款。CY 2024,CMS将继续此当前付款政策,该政策已于CY 2013生效。以下是CY 2024最终确定的项目的摘要:每年,CMS根据当前的定价方法评估药物和生物学的付款,其中包括根据指定的卧床支付分类或通过状态通过的分别付款的药物和生物学付款。CY 2024,CMS将继续此当前付款政策,该政策已于CY 2013生效。以下是CY 2024最终确定的项目的摘要:
• 暂停/延期的利息金额将在紧急措施终止时(即 2020 年 12 月 31 日)添加到贷款余额中,并且已暂停的总本金和利息金额将不会立即支付,除非受益人和金融机构另有约定。 • 法令到期后,贷款分期偿还将恢复,还款期限将被视为自动延长至所需的时间,直至最终偿还本金和利息,除非受益人和金融机构另有约定。 • 法令到期前,借款人仍有能力(前提是其已通知金融机构)支付或自愿支付任何金额以偿还其信贷额度,如果没有法令,则应根据现有信贷额度协议的条款支付。 • 暂停/延期期间不偿还分期付款不被视为违反受益人和金融机构之间的信贷协议。